Highly Accurate Blood Test for Alzheimer’s Disease Comparable or Superior to Clinical CSF Tests.

11 June, 2024

Nat Med. 2024 Feb 21. doi: 10.1038/s41591-024-02869-z. Online ahead of print.PMID: 38382645

Read the article

Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies.

JAMA Neurol. 2024 Jan 1;81(1):69-78. doi: 10.1001/jamaneurol.2023.4596.PMID: 38048096

Read the article

The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases.

Nat Commun. 2023 Oct 27;14(1):6750. doi: 10.1038/s41467-023-42305-3.PMID: 37891183 Free PMC article.

Read the article

DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease.

Read the article